{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:10:50Z","timestamp":1777965050542,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T00:00:00Z","timestamp":1459555200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00296-016-3472-9","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T05:55:56Z","timestamp":1459576556000},"page":"781-791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients"],"prefix":"10.1007","volume":"36","author":[{"given":"Goitybell","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge A.","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Mart\u00ednez-Gamboa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Roggenbuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd-R\u00fcdiger","family":"Burmester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinorah","family":"Prada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Feist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,2]]},"reference":[{"key":"3472_CR1","volume-title":"Cellular and molecular immunology","author":"AK Abbas","year":"2012","unstructured":"Abbas AK, Lichtman A, Pillai S (2012) Cellular and molecular immunology. Elseiver, Barcelona"},{"key":"3472_CR2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/annrheumdis-2013-203915","volume":"74","author":"C Wagner","year":"2015","unstructured":"Wagner C, Sokolove J, Lahey L, Bengtsson C, Saevarsdottir S, Alfredsson L et al (2015) Identification of anticitrullinated protein antibody reactivity in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 \u2018shared epitope\u2019 alleles. Ann Rheum Dis 74:579\u2013586","journal-title":"Ann Rheum Dis"},{"key":"3472_CR3","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","volume":"108","author":"J Shi","year":"2011","unstructured":"Shi J, Knevel R, Suwannalai P, Van Der Linden MP, Janssen GMC, Van Veelen PA et al (2011) Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci USA 108:17372\u201317377","journal-title":"Proc Natl Acad Sci USA"},{"key":"3472_CR4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.37830","volume":"65","author":"J Shi","year":"2013","unstructured":"Shi J, Van De Stadt L, Levarht N, Huizinga T, Toes R, Trouw L et al (2013) Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum 65:911\u2013915","journal-title":"Arthritis Rheum"},{"key":"3472_CR5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.autrev.2013.10.008","volume":"13","author":"J Shi","year":"2014","unstructured":"Shi J, Van Veelen PA, Mahler M, Janssen GM, Drijfhout JW, Huizinga TW et al (2014) Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmun Rev 13:225\u2013230","journal-title":"Autoimmun Rev"},{"key":"3472_CR6","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"3472_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar2903","volume":"12","author":"G Pruijn","year":"2010","unstructured":"Pruijn G, Wiik A, Venrooij JV (2010) The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther 12:203\u2013211","journal-title":"Arthritis Res Ther"},{"key":"3472_CR8","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/art.38017","volume":"65","author":"KM Demoruelle","year":"2013","unstructured":"Demoruelle KM, Parish M, Derber L, Kolfenbach J, Hughes-Austin J, Weisman M et al (2013) Anti-cyclic citrullinated peptide assays differ in subjects at elevated risk for rheumatoid arthritis and subjects with established disease. Arthritis Rheum 65:2243\u20132252","journal-title":"Arthritis Rheum"},{"key":"3472_CR9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/rheumatology\/keq419","volume":"50","author":"K Steendam Van","year":"2011","unstructured":"Van Steendam K, Tilleman K, Deforce D (2011) The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 50:830\u2013837","journal-title":"Rheumatology (Oxford)"},{"key":"3472_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11926-011-0193-7","volume":"13","author":"KM Demoruelle","year":"2011","unstructured":"Demoruelle KM, Deane K (2011) Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance. Curr Rheumatol Rep 13:421\u2013430","journal-title":"Curr Rheumatol Rep"},{"key":"3472_CR11","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3899\/jrheum.091236","volume":"37","author":"T Jaskowski","year":"2010","unstructured":"Jaskowski T, Hill HR, Russo KL, Lakos G, Szekanecz Z, Teodorescu M (2010) Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies. J Rheumatol 37:1582\u20131588","journal-title":"J Rheumatol"},{"key":"3472_CR12","first-page":"1027","volume":"21","author":"N Despr\u00e9s","year":"1994","unstructured":"Despr\u00e9s N, Boire G, Lopez-Longo FJ, M\u00e9nard HA (1994) The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol 21:1027\u20131033","journal-title":"J Rheumatol"},{"key":"3472_CR13","doi-asserted-by":"crossref","first-page":"250311","DOI":"10.1002\/art.22817","volume":"56","author":"H Bang","year":"2007","unstructured":"Bang H, Egerer K, Gauliard A (2007) Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 56:250311","journal-title":"Arthritis Rheum"},{"key":"3472_CR14","author":"ML D\u00edaz-Toscano","year":"2014","unstructured":"D\u00edaz-Toscano ML, Olivas-Flores EM, Zavaleta-U\u00f1iz SA, Gamez-Nava JI, Cardona-Mu\u00f1oz EG, Ponce-Guarneros M et al (2014) Comparison of two assays to determine anti-citrullinated peptide antibodies in rheumatoid arthritis in relation to other chronic inflammatory rheumatic diseases: assaying anti-modified citrullinated vimentin antibodies adds value to second-generation anti-citrullinated cyclic peptides testing. Biomed Res Int. doi: 10.1155\/2014\/198198","journal-title":"Biomed Res Int"},{"key":"3472_CR15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12291-012-0272-1","volume":"28","author":"W Zahran","year":"2013","unstructured":"Zahran W, Mahmoud M, Shalaby K, Abbas M (2013) Unique correlation between mutated citrullinated vimentin IgG autoantibodies and markers of systemic inflammation in rheumatoid arthritis patients. Ind J Clin Biochem 28:272\u2013276","journal-title":"Ind J Clin Biochem"},{"key":"3472_CR16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.37757\/MR2009V11.N3.9","volume":"11","author":"P Varona","year":"2009","unstructured":"Varona P, Herrera D, Garc\u00eda RG, Bonet M, Romero T, Venero SJ (2009) Smoking-attributable mortality in Cuba. MEDICC Rev 11:43\u201347","journal-title":"MEDICC Rev"},{"key":"3472_CR17","doi-asserted-by":"crossref","unstructured":"Da Mota LMH, Neto LL, Pereira IA, Burlingamer R, Menard H, Laurindo IM (2011) Autoantibodies in early rheumatoid arthritis\u2014Bras\u00edlia cohort\u2014results of a three-year serial analysis. Rev Bras Reumatol 51:558\u2013571. www.scielo.br\/pdf\/rbr\/v51n6\/en_v51n6a04.pdf","DOI":"10.1590\/S0482-50042011000600004"},{"key":"3472_CR18","unstructured":"Haye MJ, Retamozo S, Vetorazzi L, Peano N, D\u00edaz PE, Casta\u00f1os MS et al (2013) Anticuerpo anticitrulina y manifestaciones extra articulares en artritis reumatoidea. Medicina (Buenos Aires) 73: 21\u201325. http:\/\/www.scielo.org.ar\/scielo.php?pid=S0025-76802013000100004&script=sci_arttext"},{"key":"3472_CR19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/rheumatology\/keq220","volume":"50","author":"J Marcos","year":"2011","unstructured":"Marcos J, Waimann C, Para FD, Hogrefe J, Retamozo S, Caeiro F (2011) General characteristics of an early arthritis cohort in Argentina. Rheumatology 50:110\u2013116. doi: 10.1093\/rheumatology\/keq220","journal-title":"Rheumatology"},{"key":"3472_CR20","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/rheumatology\/keq134","volume":"49","author":"I Goeldner","year":"2010","unstructured":"Goeldner I, Skare TL, Reason I, Nisihara RM, Silva M, Shirley R (2010) Concise report Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil. Rheumatology 49:1590\u20131593","journal-title":"Rheumatology"},{"key":"3472_CR21","author":"M Juarez","year":"2015","unstructured":"Juarez M, Bang H, Hammar F, Reimer U, Dyke B, Sahbudin I et al. (2015) Identification of novel anti-acetylated vimentin antibodies in patients with early inflammatory arthritis. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2014-206785","journal-title":"Ann Rheum Dis"},{"key":"3472_CR22","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","volume":"6","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, Despres N, Lapointe E, Van Der Heijden A, Lora M, Senshu T et al (2004) Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 6:R142\u2013R150","journal-title":"Arthritis Res Ther"},{"issue":"17","key":"3472_CR23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13075-015-0638-x","volume":"20","author":"H Kokkonen","year":"2015","unstructured":"Kokkonen H, Brink M, Hansson M, Lassen E, Mathsson-Alm L, Holmdahl R et al (2015) Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis. Arthritis Res Ther 20(17):125","journal-title":"Arthritis Res Ther"},{"key":"3472_CR24","unstructured":"Kokuina H, Chico A, Carballar L, Guti\u00e9rrez A, Soto J, Est\u00e9vez M et al (2008) Rheumatoid factor: association with the radiological erosion and with the rheumatoid arthritis activity. Rev Cubana Med. www.scielo.sld.cu\/scielo.php?script=sci_arttext&pid=S0034-5232008000300004&lng=es&nrm=iso&tlng=es"},{"key":"3472_CR25","author":"L Gonzalez-Lopez","year":"2014","unstructured":"Gonzalez-Lopez L, Rocha-Mu\u00f1oz AD, Ponce-Guarneros M, Flores-Chavez A, Salazar-Paramo M, Nava A et al (2014) Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis. J Immunol Res. doi: 10.1155\/2014\/536050","journal-title":"J Immunol Res"},{"key":"3472_CR26","author":"P Suwannalai","year":"2011","unstructured":"Suwannalai P, Willemze A, Van Toorn L, Stoeken-Rijsbergen G, Levarht N, Drijfhout JW et al (2011) The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA. Arthritis Res Ther. doi: 10.1186\/ar3524","journal-title":"Arthritis Res Ther"},{"key":"3472_CR27","author":"J Stoop","year":"2014","unstructured":"Stoop J, Liu B, Shi J, Jansen D, Hegen M, Huizinga TWJ et al (2014) Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen Induced Arthritis. PLoS One. doi: 10.1371\/journal.pone.0102163","journal-title":"PLoS One"},{"key":"3472_CR28","author":"P Mydel","year":"2010","unstructured":"Mydel P, Wang Z, Brisslert M, Hellvard A, Dahlberg L, Hazen SL et al (2010) Carbamylation-dependent activation of T Cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J Immunol. doi: 10.4049\/jimmunol.1000075","journal-title":"J Immunol"},{"key":"3472_CR29","first-page":"622","volume":"32","author":"O Derganova","year":"2014","unstructured":"Derganova O, Martinez-Gamboa L, Egerer K, Bang H, Fredenhagen G, Roggenbuck D et al (2014) Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients. Clin Exp Rheumatol 32:622\u2013629","journal-title":"Clin Exp Rheumatol"},{"key":"3472_CR30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/art.23188","volume":"58","author":"L Mathsson","year":"2008","unstructured":"Mathsson L, Mullazehi M, Wick MC, Sjxberg O, Van Vollenhoven R, Klareskog L et al (2008) Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum 58:36\u201345","journal-title":"Arthritis Rheum"},{"key":"3472_CR31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12026-014-8560-x","volume":"61","author":"A Yee","year":"2015","unstructured":"Yee A, Webb T, Seaman A, Infantino M, Meacci F, Manfredi M et al (2015) Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. Immunol Res 61:24\u201330. doi: 10.1007\/s12026-014-8560-x","journal-title":"Immunol Res"},{"key":"3472_CR32","author":"A Avdeeva","year":"2014","unstructured":"Avdeeva A, Aleksandrova E, Novikov A, Smirnov A, Cherkasova M, Nasonov E (2014) The relationship of antibodies to modified citrullinated vimentin and markers of bone and cartilage destruction in rheumatoid arthritis. Int J Rheumatol. doi: 10.1155\/2014\/464585","journal-title":"Int J Rheumatol"},{"key":"3472_CR33","author":"M Burr","year":"2012","unstructured":"Burr M, Viatte S, Bukhari M, Plant D, Symmons D, Thomson W et al (2012) Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis. Arthritis Res Ther. doi: 10.1186\/ar3834","journal-title":"Arthritis Res Ther"},{"key":"3472_CR34","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1073\/pnas.1103352108","volume":"108","author":"JM Robertsa","year":"2011","unstructured":"Robertsa JM, Veresa PR, Cochranc AK, Warnekea C, Burlingd IR, Yokelsond RJ et al (2011) Isocyanic acid in the atmosphere and its possible link to smoke-related health effects. PNAS 108:8966\u20138971","journal-title":"PNAS"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3472-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-016-3472-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3472-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T02:53:02Z","timestamp":1600397582000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-016-3472-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,2]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3472"],"URL":"https:\/\/doi.org\/10.1007\/s00296-016-3472-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,2]]}}}